Margaret K Yu, MD
Nephrology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: 052572 · 052891 · 552559 · 552767 · 552827 · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yu’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A139657 · Current
Licensed to practise in California · since 2015 · expires 2027-08-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MD.MD.60017302Physician And Surgeon License · since 2008 · expires 2016-08-14ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$145,615
Medicare paid this office $145,615 for 287 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 2-3 physician visits per month (20 years or older) | 35 | $45,626 | $267 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 25 | $30,992 | $323 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $14,205 | $71 |
| Return visit (30+ min) | 65 | $8,693 | $101 |
| Long return visit (40+ min) | 33 | $5,948 | $157 |
See all 16 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 35 | $45,626 | $267 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 25 | $30,992 | $323 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $14,205 | $71 |
| Return visit (30+ min) | 65 | $8,693 | $101 |
| Long return visit (40+ min) | 33 | $5,948 | $157 |
| Dialysis services, 1 physician visit per month (20 years or older) | 11 | $5,808 | $176 |
| Dialysis procedure including 1 evaluation | 22 | $5,691 | $79 |
| Hemodialysis procedure with physician evaluation | 31 | $2,917 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,798 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,551 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,117 | $151 |
| Long return visit (40+ min) | 15 | $2,091 | $116 |
| Return visit (30+ min) | 18 | $1,670 | $83 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 27 | $1,229 | $44 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 22 | $662 | $30 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 34 | $509 | $15 |
Who their Medicare patients are
287 Original Medicare patients in 2024. Average age 71 · Under 65 23% · 85 and older 15% · Women 48% · Also on Medicaid 42% · Health risk score 5.31. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 60% · Heart failure 52% · Coronary heart disease 45% · Atrial fibrillation 40% · Depression 24% · COPD 22% · Cancer 18% · Dementia 17% · Stroke 16%.
The office billed $615,773, Medicare allowed $186,145 and paid $145,615; for 1,071 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 287 | 1,071 | 71 | 5.31 | $615,773 | $145,615 |
| 2023 | 317 | 1,172 | 71 | 5.33 | $650,441 | $156,975 |
| 2022 | 333 | 1,292 | 71 | 4.84 | $673,263 | $158,220 |
| 2021 | 329 | 1,064 | 69 | 4.39 | $558,764 | $131,510 |
| 2020 | 302 | 1,186 | 68 | 4.58 | $551,125 | $120,424 |
| 2019 | 328 | 1,200 | 68 | 4.65 | $426,590 | $109,443 |
| 2018 | 290 | 946 | 66 | 4.63 | $317,447 | $85,262 |
| 2017 | 284 | 841 | 68 | 4.46 | $292,553 | $69,541 |
| 2016 | 215 | 681 | 68 | 4.79 | $234,481 | $48,248 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 43 | $35,846 | $276 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 33 | $35,542 | $329 |
| Home dialysis services per month (20 years or older) | 14 | $18,185 | $264 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 81 | $17,000 | $73 |
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $12,041 | $188 |
| Dialysis procedure including 1 evaluation | 30 | $6,613 | $81 |
| Return visit (30+ min) | 53 | $5,671 | $83 |
| Long return visit (40+ min) | 31 | $4,963 | $124 |
| Hemodialysis procedure with physician evaluation | 34 | $3,740 | $66 |
| Return visit (30+ min) | 37 | $3,635 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,989 | $120 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,308 | $154 |
| Long return visit (40+ min) | 13 | $1,775 | $127 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $1,174 | $45 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 24 | $764 | $32 |
2022: 16 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 32 | $41,123 | $278 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 98 | $18,876 | $65 |
| Home dialysis services per month (20 years or older) | 13 | $17,865 | $275 |
| Dialysis services, 1 physician visit per month (20 years or older) | 22 | $14,676 | $188 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 16 | $13,252 | $331 |
| Return visit (30+ min) | 76 | $9,657 | $83 |
| Dialysis procedure including 1 evaluation | 29 | $8,732 | $81 |
| Long return visit (40+ min) | 28 | $4,903 | $117 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $4,799 | $123 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,582 | $176 |
| Return visit (30+ min) | 36 | $4,075 | $83 |
| Hemodialysis procedure with physician evaluation | 33 | $3,076 | $67 |
| Long return visit (40+ min) | 15 | $2,097 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,684 | $94 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 29 | $1,264 | $35 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 12 | $367 | $31 |
2021: 14 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 25 | $34,939 | $282 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 88 | $16,581 | $66 |
| Dialysis services, 1 physician visit per month (20 years or older) | 15 | $11,767 | $193 |
| Return visit (30+ min) | 67 | $7,652 | $81 |
| Dialysis procedure including 1 evaluation | 29 | $6,543 | $82 |
| Long return visit (40+ min) | 29 | $5,203 | $124 |
| Return visit (30+ min) | 41 | $5,056 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,626 | $185 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 36 | $4,542 | $126 |
| Hemodialysis procedure with physician evaluation | 31 | $3,105 | $67 |
| Long return visit (40+ min) | 13 | $1,876 | $134 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 42 | $1,682 | $34 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,432 | $95 |
| Short return visit (20+ min) | 12 | $813 | $58 |
2020: 16 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 20 | $17,430 | $229 |
| Home dialysis services per month (20 years or older) | 19 | $16,467 | $217 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 82 | $15,025 | $67 |
| Dialysis services, 1 physician visit per month (20 years or older) | 23 | $14,829 | $167 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 16 | $10,578 | $271 |
| Dialysis procedure including 1 evaluation | 26 | $8,004 | $82 |
| Return visit (30+ min) | 68 | $6,461 | $69 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,375 | $187 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $4,015 | $130 |
| Hemodialysis procedure with physician evaluation | 28 | $3,552 | $68 |
| Return visit (30+ min) | 36 | $3,543 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,226 | $97 |
| New patient visit (60+ min) | 14 | $2,105 | $150 |
| Long return visit (40+ min) | 16 | $2,103 | $105 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 31 | $1,455 | $36 |
| Short return visit (20+ min) | 20 | $888 | $42 |
2019: 17 services
| Dialysis services, 1 physician visit per month (20 years or older) | 26 | $19,092 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 89 | $17,454 | $65 |
| Return visit (30+ min) | 71 | $8,089 | $67 |
| Dialysis procedure including 1 evaluation | 24 | $6,347 | $78 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 17 | $5,984 | $222 |
| Hemodialysis procedure with physician evaluation | 46 | $5,953 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,589 | $184 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,836 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $3,396 | $94 |
| New patient visit (60+ min) | 23 | $3,347 | $146 |
| Return visit (30+ min) | 35 | $3,331 | $67 |
| Long return visit (40+ min) | 32 | $3,231 | $92 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 46 | $2,415 | $34 |
| New patient visit (60+ min) | 15 | $2,132 | $142 |
| Long return visit (40+ min) | 12 | $1,413 | $94 |
| New patient visit (45+ min) | 13 | $1,399 | $108 |
| Short return visit (20+ min) | 16 | $789 | $46 |
2018: 14 services
| Dialysis services, 1 physician visit per month (20 years or older) | 26 | $17,144 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 73 | $11,353 | $65 |
| Return visit (30+ min) | 69 | $7,881 | $66 |
| Hemodialysis procedure with physician evaluation | 49 | $6,429 | $65 |
| New patient visit (60+ min) | 43 | $6,254 | $145 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,185 | $182 |
| Dialysis procedure including 1 evaluation | 18 | $4,608 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $3,464 | $94 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,566 | $122 |
| Long return visit (40+ min) | 24 | $2,494 | $96 |
| Return visit (30+ min) | 18 | $2,140 | $63 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 43 | $1,958 | $35 |
| New patient visit (45+ min) | 11 | $1,178 | $107 |
| Short return visit (20+ min) | 15 | $691 | $46 |
2017: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $10,624 | $65 |
| Hemodialysis procedure with physician evaluation | 65 | $8,674 | $63 |
| Return visit (30+ min) | 49 | $6,142 | $65 |
| New patient visit (60+ min) | 38 | $5,569 | $147 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,714 | $181 |
| Dialysis procedure including 1 evaluation | 19 | $4,287 | $78 |
| Long return visit (40+ min) | 29 | $3,487 | $97 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 58 | $2,655 | $34 |
| New patient visit (45+ min) | 22 | $2,466 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,150 | $93 |
| New patient visit (60+ min) | 12 | $1,775 | $148 |
| Return visit (30+ min) | 15 | $1,445 | $66 |
| Short return visit (20+ min) | 24 | $1,141 | $39 |
2016: 11 services
| Hemodialysis procedure with physician evaluation | 70 | $9,699 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $8,295 | $64 |
| Dialysis procedure including 1 evaluation | 15 | $4,613 | $78 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 59 | $4,011 | $35 |
| New patient visit (60+ min) | 21 | $3,014 | $144 |
| New patient visit (45+ min) | 28 | $2,768 | $99 |
| Return visit (30+ min) | 22 | $2,241 | $70 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,606 | $89 |
| Long return visit (40+ min) | 12 | $1,288 | $92 |
| Short return visit (20+ min) | 24 | $1,230 | $46 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,204 | $93 |
Medicaid work
$57,723 in 2024
Medicaid paid $57,723 for 415 billed services this clinician did in 2024, up to 29 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 185 | $30,065 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 135 | $23,488 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 82 | $3,222 |
| Return visit (30+ min) | 13 | $948 |
| 2024 | 415 | 4 | 29 | $57,723 |
| 2023 | 487 | 5 | 26 | $52,756 |
| 2022 | 670 | 5 | 31 | $53,282 |
| 2021 | 430 | 5 | 29 | $29,956 |
| 2020 | 228 | 4 | 20 | $6,431 |
| 2019 | 75 | 2 | 16 | $2,160 |
| 2018 | 37 | 2 | 13 | $2,893 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 176 | $24,940 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 182 | $19,971 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 91 | $4,244 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 25 | $2,848 |
| Long return visit (40+ min) | 13 | $753 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 224 | $31,886 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 80 | $10,593 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 307 | $7,661 |
| Long return visit (40+ min) | 41 | $2,226 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 18 | $916 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 143 | $16,315 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 45 | $6,760 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 215 | $5,901 |
| Return visit (30+ min) | 12 | $527 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 15 | $452 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 146 | $3,058 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 12 | $1,675 |
| Return visit (30+ min) | 33 | $1,001 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 37 | $697 |
2019
| Return visit (30+ min) | 41 | $1,327 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 34 | $833 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 13 | $2,428 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 24 | $466 |
Drugs they prescribed that Part D paid
$153,105
Pharmacies billed $153,105 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 926) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
785 generic and 141 brand-name prescriptions · $153,105 in drug cost · 15 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 48 | $51,219 | $1,067 |
| Kerendia | 16 | $14,162 | $885 |
| Sevelamer Carbonate | 41 | $9,051 | $221 |
| Retacrit | 18 | $5,804 | $322 |
| Calcium Acetate | 21 | $2,711 | $129 |
See all 21 drugs
| Jardiance | 48 | $51,219 | $1,067 |
| Kerendia | 16 | $14,162 | $885 |
| Sevelamer Carbonate | 41 | $9,051 | $221 |
| Retacrit | 18 | $5,804 | $322 |
| Calcium Acetate | 21 | $2,711 | $129 |
| Losartan | 94 | $1,140 | $12 |
| Torsemide | 43 | $852 | $20 |
| Chlorthalidone | 54 | $538 | $10 |
| Amlodipine Besylate | 96 | $509 | $5 |
| Calcitriol | 19 | $395 | $21 |
| Tamsulosin | 18 | $380 | $21 |
| Carvedilol | 39 | $380 | $10 |
| Allopurinol | 40 | $291 | $7 |
| Mycophenolate Mofetil | 12 | $287 | $24 |
| Lisinopril | 39 | $281 | $7 |
| Furosemide | 47 | $235 | $5 |
| Hydralazine | 11 | $207 | $19 |
| Hydroxyzine | 12 | $129 | $11 |
| Spironolactone | 12 | $72 | $6 |
| Clonidine | 12 | $57 | $5 |
| Cephalexin | 14 | $40 | $3 |
Year by year
| 2024 | 926 | 136 | 0% (0) | 15% | $153,105 |
| 2023 | 1,076 | 145 | None | 18% | $256,554 |
| 2022 | 1,179 | 155 | 0% (0) | 19% | $203,601 |
| 2021 | 992 | 134 | 0% (0) | None | $146,400 |
| 2020 | 987 | 130 | None | None | $207,721 |
| 2019 | 739 | 120 | None | None | $118,770 |
| 2018 | 505 | 86 | None | 14% | $77,380 |
| 2017 | 398 | 66 | None | 16% | $54,081 |
| 2016 | 148 | 37 | None | 7% | $8,646 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Jardiance | 50 | $58,252 | $1,165 |
| Renvela | 13 | $34,331 | $2,641 |
| Sevelamer Carbonate | 17 | $22,279 | $1,311 |
| Procrit | 16 | $20,096 | $1,256 |
| Veltassa | 13 | $12,425 | $956 |
| Prosol | 47 | $9,255 | $197 |
| Retacrit | 18 | $5,475 | $304 |
| Calcium Acetate | 25 | $2,520 | $101 |
| Losartan | 116 | $2,442 | $21 |
| Midodrine | 20 | $1,555 | $78 |
| Amlodipine Besylate | 108 | $1,226 | $11 |
| Torsemide | 40 | $1,082 | $27 |
| Carvedilol | 69 | $941 | $14 |
| Allopurinol | 48 | $853 | $18 |
| Furosemide | 55 | $825 | $15 |
| Chlorthalidone | 44 | $764 | $17 |
| Hydralazine | 20 | $700 | $35 |
| Tamsulosin | 12 | $573 | $48 |
| Doxazosin Mesylate | 18 | $494 | $27 |
| Lisinopril | 37 | $297 | $8 |
| Hydroxyzine | 12 | $270 | $23 |
| Mycophenolate Mofetil | 11 | $263 | $24 |
| Atorvastatin | 11 | $195 | $18 |
| Gabapentin | 14 | $179 | $13 |
| Spironolactone | 13 | $156 | $12 |
| Hydrochlorothiazide | 16 | $114 | $7 |
| Metoprolol | 12 | $69 | $6 |
| Cephalexin | 11 | $30 | $3 |
2022: 28 drugs
| Jardiance | 36 | $44,351 | $1,232 |
| Renvela | 15 | $31,115 | $2,074 |
| Farxiga | 15 | $16,997 | $1,133 |
| Prosol | 73 | $12,249 | $168 |
| Calcium Acetate | 52 | $9,237 | $178 |
| Sevelamer Carbonate | 21 | $8,178 | $389 |
| Retacrit | 15 | $3,331 | $222 |
| Clonidine | 31 | $3,111 | $100 |
| Potassium Chloride | 22 | $2,648 | $120 |
| Amlodipine Besylate | 115 | $1,669 | $15 |
| Furosemide | 78 | $1,268 | $16 |
| Losartan | 99 | $1,256 | $13 |
| Carvedilol | 52 | $1,130 | $22 |
| Chlorthalidone | 54 | $1,097 | $20 |
| Torsemide | 39 | $1,056 | $27 |
| Allopurinol | 36 | $776 | $22 |
| Hydralazine | 37 | $716 | $19 |
| Lisinopril | 41 | $714 | $17 |
| Calcitriol | 24 | $628 | $26 |
| Doxazosin Mesylate | 21 | $432 | $21 |
| Tamsulosin | 20 | $383 | $19 |
| Mycophenolate Mofetil | 14 | $368 | $26 |
| Valsartan | 15 | $359 | $24 |
| Spironolactone | 17 | $144 | $8 |
| Gabapentin | 14 | $129 | $9 |
| Metoprolol | 17 | $95 | $6 |
| Hydrochlorothiazide | 15 | $56 | $4 |
| Cephalexin | 13 | $36 | $3 |
2021: 27 drugs
| Renvela | 17 | $29,415 | $1,730 |
| Jardiance | 26 | $24,989 | $961 |
| Cinacalcet | 13 | $8,861 | $682 |
| Calcium Acetate | 36 | $8,161 | $227 |
| Retacrit | 19 | $6,437 | $339 |
| Prograf | 12 | $4,494 | $374 |
| Potassium Chloride | 12 | $3,379 | $282 |
| Sevelamer Carbonate | 17 | $1,789 | $105 |
| Mycophenolate Mofetil | 18 | $1,519 | $84 |
| Chlorthalidone | 46 | $1,314 | $29 |
| Torsemide | 18 | $1,000 | $56 |
| Amlodipine Besylate | 104 | $905 | $9 |
| Losartan | 60 | $893 | $15 |
| Calcitriol | 20 | $791 | $40 |
| Hydralazine | 44 | $693 | $16 |
| Lidocaine-Prilocaine | 31 | $586 | $19 |
| Doxazosin Mesylate | 33 | $547 | $17 |
| Tamsulosin | 22 | $508 | $23 |
| Lisinopril | 47 | $480 | $10 |
| Furosemide | 57 | $442 | $8 |
| Carvedilol | 50 | $433 | $9 |
| Allopurinol | 26 | $407 | $16 |
| Valsartan | 20 | $281 | $14 |
| Spironolactone | 21 | $263 | $13 |
| Atenolol | 12 | $156 | $13 |
| Hydrochlorothiazide | 20 | $111 | $6 |
| Trazodone | 11 | $67 | $6 |
2020: 25 drugs
| Jardiance | 30 | $34,849 | $1,162 |
| Veltassa | 18 | $26,357 | $1,464 |
| Renvela | 15 | $23,832 | $1,589 |
| Cinacalcet | 12 | $15,101 | $1,258 |
| Calcium Acetate | 59 | $9,606 | $163 |
| Sevelamer Carbonate | 29 | $6,097 | $210 |
| Epogen | 14 | $4,802 | $343 |
| Prograf | 12 | $4,428 | $369 |
| Chlorthalidone | 47 | $1,327 | $28 |
| Hydralazine | 46 | $1,305 | $28 |
| Losartan | 81 | $1,258 | $16 |
| Mycophenolate Mofetil | 17 | $1,148 | $68 |
| Amlodipine Besylate | 105 | $727 | $7 |
| Furosemide | 82 | $708 | $9 |
| Calcitriol | 15 | $654 | $44 |
| Carvedilol | 45 | $574 | $13 |
| Lisinopril | 36 | $482 | $13 |
| Doxazosin Mesylate | 20 | $473 | $24 |
| Torsemide | 14 | $459 | $33 |
| Allopurinol | 17 | $288 | $17 |
| Valsartan | 13 | $183 | $14 |
| Spironolactone | 12 | $174 | $14 |
| Hydrochlorothiazide | 20 | $102 | $5 |
| Lidocaine-Prilocaine | 11 | $62 | $6 |
| Cephalexin | 12 | $32 | $3 |
2019: 22 drugs
| Velphoro | 11 | $32,261 | $2,933 |
| Veltassa | 18 | $17,489 | $972 |
| Cinacalcet | 12 | $15,410 | $1,284 |
| Sevelamer Carbonate | 17 | $8,347 | $491 |
| Procrit | 12 | $5,062 | $422 |
| Clinisol | 39 | $4,354 | $112 |
| Epogen | 11 | $2,549 | $232 |
| Calcium Acetate | 17 | $1,625 | $96 |
| Losartan | 59 | $867 | $15 |
| Chlorthalidone | 29 | $790 | $27 |
| Amlodipine Besylate | 93 | $747 | $8 |
| Hydralazine | 21 | $597 | $28 |
| Carvedilol | 44 | $541 | $12 |
| Torsemide | 22 | $516 | $23 |
| Doxazosin Mesylate | 22 | $476 | $22 |
| Calcitriol | 13 | $465 | $36 |
| Furosemide | 50 | $440 | $9 |
| Allopurinol | 20 | $297 | $15 |
| Atorvastatin | 12 | $279 | $23 |
| Tamsulosin | 11 | $236 | $21 |
| Lisinopril | 21 | $200 | $10 |
| Hydrochlorothiazide | 18 | $64 | $4 |
2018: 16 drugs
| Sensipar | 13 | $21,210 | $1,632 |
| Sevelamer Carbonate | 16 | $18,706 | $1,169 |
| Procrit | 12 | $3,087 | $257 |
| Potassium Citrate Er | 20 | $2,769 | $138 |
| Chlorthalidone | 30 | $1,098 | $37 |
| Doxazosin Mesylate | 17 | $488 | $29 |
| Calcitriol | 20 | $428 | $21 |
| Losartan | 36 | $385 | $11 |
| Amlodipine Besylate | 58 | $362 | $6 |
| Furosemide | 38 | $359 | $9 |
| Carvedilol | 24 | $247 | $10 |
| Omeprazole | 12 | $210 | $18 |
| Allopurinol | 12 | $208 | $17 |
| Lisinopril | 23 | $208 | $9 |
| Torsemide | 12 | $206 | $17 |
| Hydrochlorothiazide | 19 | $127 | $7 |
2017: 12 drugs
| Potassium Citrate Er | 11 | $808 | $73 |
| Chlorthalidone | 14 | $348 | $25 |
| Furosemide | 32 | $259 | $8 |
| Spironolactone | 18 | $237 | $13 |
| Torsemide | 13 | $236 | $18 |
| Amlodipine Besylate | 42 | $229 | $5 |
| Losartan | 33 | $226 | $7 |
| Carvedilol | 20 | $187 | $9 |
| Lisinopril | 28 | $163 | $6 |
| Pantoprazole | 13 | $128 | $10 |
| Omeprazole | 11 | $109 | $10 |
| Hydrochlorothiazide | 11 | $48 | $4 |
2016: 3 drugs
| Valsartan | 11 | $326 | $30 |
| Amlodipine Besylate | 41 | $248 | $6 |
| Hydrochlorothiazide | 17 | $58 | $3 |
Money from drug and device companies
$20 in 2024
| 2024 | 1 | 1 | None | $20 |
| 2021 | 1 | 1 | None | $125 |
| 2020 | 2 | 3 | $810 | $849 |
| 2019 | 2 | 9 | None | $278 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ANI Pharmaceuticals | Purified Cortrophin Gel | $20 | 1 payment
|
See the published payment
| ANI Pharmaceuticals | Meals · 2024-08-27 | Purified Cortrophin Gel | $20 |
See earlier years (2021, 2020, 2019)
2021: $125
| Ablative Solutions | None | $125 | 1 payment
|
2020: $849
| Bayer HealthCare Pharmaceuticals | Non-Covered | $810 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $39 | 2 payments
|
2019: $278
| Novartis Pharmaceuticals | Beovu | $153 | 7 payments
|
| Gilead Sciences | None | $125 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| AstraZeneca Pharmaceuticals LP · A Study To Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease · 2019 | Their institution | $47,719 |
| AstraZeneca Pharmaceuticals LP · A Study To Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease · 2020 | Their institution | $45,287 |
| AstraZeneca Pharmaceuticals LP · A Phase III, Randomised, Multicentre, Double-Blind Study To Evaluate the Efficacy, Safety and Tolerability of Zibotentan/Dapagliflozin Fdc Compared To Dapagliflozin Alone in Participants With Chronic Kidney Disease and High Proteinuria · 2025 | Their institution | $19,635 |
| Gilead Sciences, Inc. · Mosaic - A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects With Moderate To Advanced Diabetic Kidney Disease · 2020 | Their institution | $5,154 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1811173735
- Licence
- CA A139657, WA MD60017302California A139657: Current · expires 2027-08-31Washington MD.MD.60017302: Expired
- Trained
- Stanford University School of Medicine, 2005
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2008-01-10
- NPI last updated
- 2024-04-24
- NPI record certified
- 2024-04-24
This is when the NPI record was last certified, not a medical board exam.